Medincell’s Post

🚀 Pharmaceutical manufacturers are increasingly investing in drugs with potential across multiple diseases, a strategy known as "pipeline-in-a-pill." This approach is becoming as familiar in R&D as "string of pearls" is in dealmaking, opening doors for significant revenue growth through indication expansion. 🔬 An analysis of the industry’s top-selling drugs highlights the importance of this strategy. Among the 20 best-selling drugs launched since 2014, half have been approved by the FDA for three or more indications, with seven receiving approval for five or more. 💡 This trend showcases the immense value of indication expansion. However, it also raises questions about whether this growth pattern can be sustained at the same pace in the future. Here's a closer look at the Biggest Sellers By Number Of Indications. 📈 #Pharma #Innovation #R&D #Healthcare #IndicationExpansion #PipelineInAPill #Citeline #Blockbuster

"Times Drugs: Your Partner for Profitable Pharma Ventures! 💼💊 Unlock boundless opportunities with our PCD Pharma Franchise offerings. Explore the future of pharmaceuticals. Contact us at 9891016444 today! ☎️ #PharmaVentures #TimesDrugs #PCD #Healthcare #Pharmaceuticals #Medical #PharmaBusiness #Partnership #Opportunity #PharmaFranchise"

Thrilled to share that Basilea Pharmaceutica (SIX: #BSLN) has just secured the rights to #fosmanogepix, a cutting-edge, broad-spectrum antifungal, through an asset purchase agreement with Amplyx, now a subsidiary of Pfizer Inc. 🚀 This #Swiss drugmaker continues to make strategic moves in the pharmaceutical landscape. 🌍 Global Impact: Basilea's recent acquisition expands its portfolio, enhancing their position in the competitive pharmaceutical market. This move emphasizes their commitment to innovation and addressing critical healthcare needs. 🔬 Clinical Advancements: Fosmanogepix, a clinical-stage #antifungal candidate, holds significant promise in the fight against fungal #infections. This development aligns with Basilea's dedication to advancing healthcare solutions. 🌐 Industry Collaboration: This acquisition also highlights the dynamic collaborations shaping the pharmaceutical industry, showcasing the importance of strategic partnerships for mutual growth. 📈 Strategic Vision: With this addition and the acquisition of rights to a pre-clinical antifungal compound, Basilea Pharmaceutica demonstrates a forward-looking approach to shaping the future of antifungal therapies. Connect with me to stay updated on the latest developments in the pharmaceutical industry! 🤝 Repost to share this valuable update with your network. Follow for more insights into the evolving world of healthcare. 🌐#pharmaceutical #pharmaindustry #BasileaPharma

On Episode 293 of #TheCoreReport, Govindraj Ethiraj chats with Sheetal Sapale, VP Commercial at Pharmarack. Dive into the evolving pharmaceutical landscape and gain valuable insights into key trends impacting the industry.   Tune in to explore: ·     A spike in wholesale inflation  ·    The intricate relationships in India’s pharmaceutical sector Get the insights you need to navigate the evolving pharmaceutical landscape. Click here: https://lnkd.in/dsUeGqiU #Pharmarack #PharmInsights #PharmaIndustry #Pharmanews #Pharmatrends

Do you want to know how we can help with your formulation development projects? Meet us on DDS in Anaheim. Let us know, and we will provide you with proof that we understand what we are talking about when it comes to drug formulation, CMC, clinical development, bioanalytics, manufacturing, and much more. This is our Conscio Group - Quality Science for a Healthy Future

Discover firsthand the prowess of our pharmaceutical industry ace! Meet Andreas Kaparidis, a distinguished leader with over 2 decades of experience in the pharmaceuticals industry. His expertise in fostering client relationships and identifying business prospects is unparalleled. He is an invaluable asset to Infollion, offering strategic insights to clients that drive success. To connect with Andreas Kaparidis or to learn more about Infollion Ace Experts, reach out to us at [email protected]. #EyeForTheBestFit #InfollionResearchServices #PharmaIndustryExpert #pharmaceuticals #pharmaindustry #BusinessStrategy #StrategicLeader #AceConsultant #ExpertNetwork #ExpertTestimonial #GigEconomy

Explore the strategic roadmap of #India's thriving #pharmaceutical sector with insights from Prasad G V, Chairman, CII National Committee on Pharmaceuticals and Co-Chairman & Managing Director, Dr. Reddy's Laboratories. Read #CIIBlog, 'Navigating the Future: India’s Burgeoning Pharmaceutical Sector' to delve into strategies propelling the industry forward. https://lnkd.in/g8fyTXWv #cii4india #NewIndia CII Healthcare Department

India's Pharmaceutical sector - The roadmap. Investment in R&D and digitisation will put India on the map of the global healthcare paradigm. Skill development is the key here, to seize the opportunity.